If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where John Park is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Melanoma Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
clopidogrel Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Preexisting Condition Coverage Medicine & Life Sciences
Drug-Eluting Stents Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2019

Research Outputs 2010 2019

  • 541 Citations
  • 8 h-Index
  • 12 Article
  • 1 Letter
  • 1 Review article

Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma

Hwang, S. J. E., Park, J. J. W., Wakade, D., Chou, S., Byth, K. & Fernández-Peñas, P., Apr 2019, In : Melanoma Research. 29, 2, p. 172-177 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Cytotoxic T-Lymphocytes

Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma

da Silva, I. P., Wang, K. Y. X., Wilmott, J. S., Holst, J., Carlino, M. S., Park, J. J., Quek, C., Wongchenko, M., Yan, Y., Mann, G., Johnson, D. B., McQuade, J. L., Rai, R., Kefford, R. F., Rizos, H., Scolyer, R. A., Yang, J. Y. H., Long, G. V. & Menzies, A. M., 15 Feb 2019, In : Clinical Cancer Research. 25, 4, p. 1272-1279 8 p.

Research output: Contribution to journalArticleResearchpeer-review

MAP Kinase Signaling System
Dual Specificity Phosphatase 6

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection

Tio, M., Rai, R., Ezeoke, O. M., McQuade, J. L., Zimmer, L., Khoo, C., Park, J. J., Spain, L., Turajlic, S., Ardolino, L., Yip, D., Goldinger, S. M., Cohen, J. V., Millward, M., Atkinson, V., Kane, A. Y., Ascierto, P. A., Garbe, C., Gutzmer, R., Johnson, D. B. & 5 othersRizvi, H. A., Joshua, A. M., Hellmann, M. D., Long, G. V. & Menzies, A. M., 1 Nov 2018, In : European Journal of Cancer. 104, p. 137-144 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Hepatitis C
Hepatitis B

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

McQuade, J. L., Daniel, C. R., Hess, K. R., Mak, C., Wang, D. Y., Rai, R. R., Park, J. J., Haydu, L. E., Spencer, C., Wongchenko, M., Lane, S., Lee, D. Y., Kaper, M., McKean, M., Beckermann, K. E., Rubinstein, S. M., Rooney, I., Musib, L., Budha, N., Hsu, J. & 26 othersNowicki, T. S., Avila, A., Haas, T., Puligandla, M., Lee, S., Fang, S., Wargo, J. A., Gershenwald, J. E., Lee, J. E., Hwu, P., Chapman, P. B., Sosman, J. A., Schadendorf, D., Grob, J. J., Flaherty, K. T., Walker, D., Yan, Y., McKenna, E., Legos, J. J., Carlino, M. S., Ribas, A., Kirkwood, J. M., Long, G. V., Johnson, D. B., Menzies, A. M. & Davies, M. A., 1 Mar 2018, In : The Lancet Oncology. 19, 3, p. 310-322 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Body Mass Index
Drug Therapy

Oncogenic signaling in uveal melanoma

Park, J., Diefenbach, R. J., Joshua, A. M., Kefford, R. F., Carlino, M. S. & Rizos, H., Nov 2018, In : Pigment Cell and Melanoma Research. 31, 6, p. 661-672 12 p.

Research output: Contribution to journalReview articleResearchpeer-review

Eye Neoplasms
Peptide Initiation Factors